NASDAQ:MOTS - Motus GI Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.70 +0.15 (+3.30 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$4.70
Today's Range$4.35 - $4.70
52-Week Range$3.75 - $7.85
Volume13,174 shs
Average Volume114,737 shs
Market Capitalization$71.19 million
P/E Ratio-3.67
Dividend YieldN/A
BetaN/A

About Motus GI (NASDAQ:MOTS)

Motus GI logoMotus GI Holdings, Inc., a medical technology company, focuses on the development and commercialization of the Pure-Vu System. Its Pure-Vu System is designed to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. Motus GI Holdings, Inc. is based in Fort Lauderdale, Florida.

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MOTS
CUSIPN/A
Phone786-459-1831

Debt

Debt-to-Equity RatioN/A
Current Ratio12.32
Quick Ratio12.31

Price-To-Earnings

Trailing P/E Ratio-3.67
Forward P/E Ratio-4.31
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales7,355.50
Cash FlowN/A
Price / CashN/A
Book Value$1.10 per share
Price / Book4.27

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees39
Outstanding Shares15,650,000

Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

What price target have analysts set for MOTS?

2 brokerages have issued 1 year target prices for Motus GI's stock. Their forecasts range from $7.00 to $7.00. On average, they expect Motus GI's stock price to reach $7.00 in the next year. View Analyst Ratings for Motus GI.

Who are some of Motus GI's key competitors?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Mark Pomeranz, CEO & Director (Age 56)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 47)
  • Mr. Todd Van Emburgh, Pres
  • Ms. Hagit Ephrath, VP Health Economics, Regulatory & Clinical Affairs
  • Gil Balog, Gen. Mang. of Israel

When did Motus GI IPO?

(MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Has Motus GI been receiving favorable news coverage?

Media coverage about MOTS stock has been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Motus GI earned a coverage optimism score of 0.22 on Accern's scale. They also gave press coverage about the company an impact score of 48.29 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are Motus GI's major shareholders?

Motus GI's stock is owned by many different of retail and institutional investors. Top institutional investors include Highbridge Capital Management LLC (1.28%) and Hilltop Holdings Inc. (0.72%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Life Sciences Maste Perceptive and Mark Pomeranz. View Institutional Ownership Trends for Motus GI.

Which institutional investors are buying Motus GI stock?

MOTS stock was acquired by a variety of institutional investors in the last quarter, including Highbridge Capital Management LLC and Hilltop Holdings Inc.. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Life Sciences Maste Perceptive and Mark Pomeranz. View Insider Buying and Selling for Motus GI.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $4.70.

How big of a company is Motus GI?

Motus GI has a market capitalization of $71.19 million and generates $10,000.00 in revenue each year. The company earns $-13,200,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis. Motus GI employs 39 workers across the globe.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 786-459-1831 or via email at [email protected]


MarketBeat Community Rating for Motus GI (MOTS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  29
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Motus GI (NASDAQ:MOTS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Motus GI in the last 12 months. Their average twelve-month price target is $7.00, suggesting that the stock has a possible upside of 48.94%. The high price target for MOTS is $7.00 and the low price target for MOTS is $7.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.00$7.00N/AN/A
Price Target Upside: 48.94% upside41.41% upsideN/AN/A

Motus GI (NASDAQ:MOTS) Consensus Price Target History

Price Target History for Motus GI (NASDAQ:MOTS)

Motus GI (NASDAQ:MOTS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/12/2018OppenheimerInitiated CoverageOutperform$7.00HighView Rating Details
3/11/2018Piper Jaffray CompaniesInitiated CoverageOverweight$7.00HighView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Dividends

Motus GI (NASDAQ:MOTS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Motus GI (NASDAQ MOTS) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 22.38%
Insider Trading History for Motus GI (NASDAQ:MOTS)

Motus GI (NASDAQ MOTS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2018Gary E JacobsDirectorBuy5,000$5.24$26,200.00View SEC Filing  
2/16/2018Andrew Lawrence TaylorCFOBuy2,000$5.00$10,000.00View SEC Filing  
2/16/2018David P HochmanChairmanBuy115,000$5.00$575,000.00View SEC Filing  
2/16/2018Gary J PrudenDirectorBuy50,000$5.00$250,000.00View SEC Filing  
2/16/2018Life Sciences Maste PerceptiveMajor ShareholderBuy1,000,000$5.00$5,000,000.00View SEC Filing  
2/16/2018Mark PomeranzCEOBuy8,000$5.00$40,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Motus GI (NASDAQ MOTS) News Headlines

Source:
DateHeadline
Motus GI (MOTS) versus Its Rivals Head to Head AnalysisMotus GI (MOTS) versus Its Rivals Head to Head Analysis
www.americanbankingnews.com - May 23 at 11:21 AM
Motus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized PatientsMotus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized Patients
finance.yahoo.com - May 23 at 8:19 AM
Head to Head Analysis: Motus GI (MOTS) and Its CompetitorsHead to Head Analysis: Motus GI (MOTS) and Its Competitors
www.americanbankingnews.com - May 22 at 1:33 PM
Critical Review: Motus GI (MOTS) versus Its CompetitorsCritical Review: Motus GI (MOTS) versus Its Competitors
www.americanbankingnews.com - May 21 at 11:14 PM
Motus GI Holdings (MOTS) Director Buys $26,200.00 in StockMotus GI Holdings (MOTS) Director Buys $26,200.00 in Stock
www.americanbankingnews.com - May 21 at 10:16 AM
Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® SystemMotus GI Announces Issuance of Chinese Patent for the Pure-Vu® System
finance.yahoo.com - May 21 at 7:58 AM
 Analysts Expect Motus GI Holdings (MOTS) to Announce -$0.29 Earnings Per Share Analysts Expect Motus GI Holdings (MOTS) to Announce -$0.29 Earnings Per Share
www.americanbankingnews.com - May 20 at 3:24 AM
Motus GI (MOTS) versus Its Rivals Financial AnalysisMotus GI (MOTS) versus Its Rivals Financial Analysis
www.americanbankingnews.com - May 19 at 11:14 PM
Motus GI Holdings (MOTS) Forecasted to Earn Q2 2018 Earnings of ($0.27) Per ShareMotus GI Holdings (MOTS) Forecasted to Earn Q2 2018 Earnings of ($0.27) Per Share
www.americanbankingnews.com - May 18 at 7:13 AM
Brokerages Expect Motus GI Holdings (MOTS) to Announce ($0.30) EPSBrokerages Expect Motus GI Holdings (MOTS) to Announce ($0.30) EPS
www.americanbankingnews.com - May 17 at 1:49 PM
Head-To-Head Contrast: Motus GI (MOTS) & Its PeersHead-To-Head Contrast: Motus GI (MOTS) & Its Peers
www.americanbankingnews.com - May 17 at 10:12 AM
Motus GI Reports 2018 First Quarter Financial Results and Provides Business UpdateMotus GI Reports 2018 First Quarter Financial Results and Provides Business Update
finance.yahoo.com - May 15 at 8:18 AM
Head to Head Contrast: Motus GI (MOTS) and The CompetitionHead to Head Contrast: Motus GI (MOTS) and The Competition
www.americanbankingnews.com - May 5 at 11:18 PM
Head to Head Review: Motus GI (MOTS) vs. Its CompetitorsHead to Head Review: Motus GI (MOTS) vs. Its Competitors
www.americanbankingnews.com - May 5 at 7:24 PM
Motus GI (MOTS) Lifted to "Hold" at ValuEngineMotus GI (MOTS) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - May 2 at 11:38 PM
Zacks: Analysts Set $7.00 Price Target for Motus GI Holdings (MOTS)Zacks: Analysts Set $7.00 Price Target for Motus GI Holdings (MOTS)
www.americanbankingnews.com - May 2 at 3:34 PM
-$0.24 EPS Expected for Motus GI Holdings (MOTS) This Quarter-$0.24 EPS Expected for Motus GI Holdings (MOTS) This Quarter
www.americanbankingnews.com - May 2 at 3:23 PM
Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAFMotus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF
finance.yahoo.com - April 16 at 3:19 PM
Motus GI Announces 2017 Financial Results and Provides Business OutlookMotus GI Announces 2017 Financial Results and Provides Business Outlook
finance.yahoo.com - April 6 at 6:46 AM
ValuEngine Lowers Motus GI (MOTS) to SellValuEngine Lowers Motus GI (MOTS) to Sell
www.americanbankingnews.com - April 3 at 12:11 PM
Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® SystemMotus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System
finance.yahoo.com - March 27 at 3:18 PM
Motus GI Holdings Incs (MOTS) Quiet Period Set To End  on March 26thMotus GI Holdings Inc's (MOTS) Quiet Period Set To End on March 26th
www.americanbankingnews.com - March 19 at 1:23 AM
Analysts Issue Forecasts for Motus GI Holdings Incs Q1 2018 Earnings (MOTS)Analysts Issue Forecasts for Motus GI Holdings Inc's Q1 2018 Earnings (MOTS)
www.americanbankingnews.com - March 14 at 7:20 AM
Motus GI to Present at the Oppenheimer 28th Annual Healthcare ConferenceMotus GI to Present at the Oppenheimer 28th Annual Healthcare Conference
finance.yahoo.com - March 13 at 3:19 PM
Motus GI (MOTS) Research Coverage Started at OppenheimerMotus GI (MOTS) Research Coverage Started at Oppenheimer
www.americanbankingnews.com - March 12 at 11:26 AM
Piper Jaffray Companies Initiates Coverage on Motus GI (MOTS)Piper Jaffray Companies Initiates Coverage on Motus GI (MOTS)
www.americanbankingnews.com - March 11 at 8:18 PM
BRIEF-Motus GI Receives CE Mark Approval For The Pure-Vu SystemBRIEF-Motus GI Receives CE Mark Approval For The Pure-Vu System
www.reuters.com - February 27 at 3:16 PM
Motus GI Receives CE Mark Approval for the Pure-Vu® SystemMotus GI Receives CE Mark Approval for the Pure-Vu® System
finance.yahoo.com - February 27 at 3:16 PM
IPO News This Week: Holiday Doldrums ContinueIPO News This Week: Holiday Doldrums Continue
247wallst.com - February 25 at 3:15 PM
Insider Buying: Motus GI Holdings Inc (MOTS) Major Shareholder Purchases 1,000,000 Shares of StockInsider Buying: Motus GI Holdings Inc (MOTS) Major Shareholder Purchases 1,000,000 Shares of Stock
www.americanbankingnews.com - February 21 at 6:12 PM
Motus GI Holdings Inc (MOTS) Chairman David P. Hochman Purchases 115,000 SharesMotus GI Holdings Inc (MOTS) Chairman David P. Hochman Purchases 115,000 Shares
www.americanbankingnews.com - February 21 at 12:31 PM
Insider Buying: Motus GI Holdings Inc (MOTS) CEO Acquires 8,000 Shares of StockInsider Buying: Motus GI Holdings Inc (MOTS) CEO Acquires 8,000 Shares of Stock
www.americanbankingnews.com - February 21 at 9:14 AM
Insider Buying: Motus GI Holdings Inc (MOTS) Director Buys 50,000 Shares of StockInsider Buying: Motus GI Holdings Inc (MOTS) Director Buys 50,000 Shares of Stock
www.americanbankingnews.com - February 21 at 9:14 AM
Motus GI Holdings Plans $26 Million IPO for February 9th (MOTS)Motus GI Holdings Plans $26 Million IPO for February 9th (MOTS)
www.americanbankingnews.com - February 5 at 1:16 AM

SEC Filings

Motus GI (NASDAQ:MOTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Motus GI (NASDAQ MOTS) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.